Xenon Pharmaceuticals Inc. Approves Changes to the Composition of the Board's Committees
January 03, 2017 at 04:53 pm EST
Effective January 2, 2017, the board of directors of Xenon Pharmaceuticals Inc. approved certain changes to the composition of the Board's committees. Specifically, Dr. Richard Scheller was appointed to the Board's Compensation Committee replacing Mr. Michael Tarnow and Ms. Dawn Svoronos was appointed to the Board's Nominating and Corporate Governance Committee replacing Dr. Mohammad Azab.